
BaLu™
Shining a New Light on Infection Prevention
Meet BaLu™ — the innovative UV light solution designed to reduce catheter-associated infections. Compatible with major catheter models, BaLu™ offers seamless protection, enhanced patient safety, and a proactive approach to infection prevention.

Benefits
Previous attempts have been made to develop devices with UV light to prevent bacterial proliferation.
These have been non-wearables, difficult to use and apply, time-consuming, and even patient-harmful. VIOBAC offers the first holistic solution: a small, simple, and easy-to-apply wearable click-on device, which, in a prophylactic manner, prevents infections during the whole application period without patient harm.
The device is clicked on the indwelling catheter outside the patient without needing daily removal. No external wires, strings, or power supply - truly wearable.

Fewer Infections
Catheter-associated urinary tract infections are a leading cause of hospital infections, affecting up to 30% of catheterized patients. BaLu™ uses UV technology to prevent bacterial buildup, reducing infection risks and supporting safer patient outcomes.

Less Use of Antibiotics
Reducing catheter-associated urinary tract infections means fewer antibiotic treatments and a lower risk of antibiotic resistance and side effects. BaLu™ offers a proactive solution that helps limit antibiotic use, supporting long-term patient health and better hospital outcomes.

Better Care
With BaLu™, healthcare staff spend less time managing infections and more time on essential patient care. By reducing infection-related hospital stays, BaLu™ helps nurses and doctors focus on what matters most—providing dedicated, hands-on care to every patient.

Seamless Compatibility
BaLu™ is designed to work with common catheter models and sizes, making it easy to integrate into existing healthcare practices without the need for specialized equipment. This compatibility ensures that healthcare providers can offer enhanced infection protection across a wide range of catheter types.

Lower Healthcare Costs
BaLu™ reduces the risk of costly CAUTIs, which often result in longer hospital stays and additional treatments. By lowering infection rates, BaLu™ helps hospitals save on resources, delivering a more cost-effective solution for patient care.

Faster Recovery Times
By preventing CAUTIs at the source, BaLu™ helps patients avoid extended recovery times due to infection. This proactive approach leads to quicker hospital discharge, supporting smoother, faster recoveries for catheterized patients.

CAUTIs in Hospitals
Catheter-associated urinary tract infections (CAUTIs) are the most common hospital-acquired infections, accounting for up to 40% of all hospital infections globally and over 1 million cases annually in the U.S.
Approximately 25% of hospitalized patients undergo catheterization, with nearly 30% developing a CAUTI. The risk of infection increases daily, and after three weeks, virtually all catheterized patients will develop a UTI. This is due to biofilms—bacterial communities that adhere to catheter surfaces—making infections resistant to both the immune system and antibiotics, and nearly impossible to eradicate without removing the catheter.
BaLu™ UV Protection
Viobac’s BaLu™ device uses UV light to prevent CAUTIs by targeting bacteria at the source. The patented click-on device emits germicidal UV light that disrupts bacterial DNA on the catheter surface, stopping bacteria from reproducing and forming biofilms.
This UV technology provides a non-invasive, chemical-free approach to infection control that prevents bacterial resistance. Compatible with all major catheter models, BaLu™ integrates easily into existing practices, offering a scalable and proactive solution to significantly reduce infection risks.


Safer Care with BaLu™
By preventing infections at the point of catheter use, BaLu™ enhances patient safety and reduces the need for antibiotics.
With fewer infections, patients experience shorter hospital stays and faster recoveries, improving overall healthcare efficiency.
BaLu™ embodies Viobac’s commitment to safe, sustainable infection prevention. It is a practical advancement in healthcare technology that prioritizes patient well-being and improved clinical outcomes.
Timeline
BaLu™ is making steady progress toward becoming a trusted solution in infection prevention. With essential patents secured, strong results from laboratory testing, and a partnership to enhance product development, we’re building a solid foundation for BaLu™ to make a real difference in healthcare.
Patent

Securing essential IP rights, with a national patent granted and an international (PCT) patent pending.
Laboratory PoC

Our solution’s efficacy has been proven in professional labs, and we’re continuing to gather strong evidence.
R&D

We’ve partnered with a leading medical equipment developer to refine our product and meet regulatory standards.
Commercialisation

With proven investors and a sound board BaLu™, is on the way the way to true commercialisation.
Awards

University Startup World Cup
VIOBAC has been voted the best university startup in the world within the health category with incorporation of the UN's 17 Sustainable Development Goals, 2019.

Nordic Health Tech Talents
VIOBAC has been chosen as one of the 10 selected participants for NHTT 2019 hosted by Venture Cup
